Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Press Releases
April 13, 2025

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

NEW YORK, April 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM),

bradford

The Bradford Era

Local & Social